← Leaderboards
Rupak Shivakoti
Johns Hopkins University
$5,705,971
Attributed
$6,518,979
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2016–25$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,518,979 · 5
By mechanism
R01$5,072,569 · 2
R00$731,230 · 1
R21$452,784 · 1
K99$262,396 · 1
Top collaborators
- Jim Aizire5 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Gislin Dagnelie$12,579,100
- David Wesley Dowdy$17,286,098
- Thomas B Woolf$1,315,769
- William W Eaton$22,660,492
- Colleen Hanrahan$804,197
Others in their field
Top investigators on “Probiotics”
- Gary Fanger · Rise Therapeutics, Llc$26,547,866
- Sarkis K Mazmanian · California Institute Of Technology$10,460,394
- Sabita Roy · University Of Minnesota Twin Cities$9,108,304
- Joel Palefsky · University Of California San Francisco$8,712,471
- Phillip I Tarr · Seattle Children'S Hospital$8,647,804
- Tal Danino · Columbia Univ New York Morningside$8,217,641
Research focus
ProbioticsInfantMicrobiomeWomanAntiretroviral TherapyCohortHigh RiskHiv InfectionsQuestionnairesHiv-Exposed Uninfected InfantPathway InteractionsGrowthMorbidity - Disease RateRandomizedChildBiologicalLinkRandomized TrialAffectMothersMetabolic PathwayInflammationInflammatory MarkerInfant Outcome
Grant awards (16)
Trial of Human Milk Oligosaccharide-based synbiotics for HIV-exposed uninfected children$757,348
R01 · FY2025 · HD · contact PI
Appetite regulation with DTG based ART in postpartum women living with HIV and their infants (Ar-DART)$190,679
R21 · FY2025 · HD
Trial of Human Milk Oligosaccharide-based synbiotics for HIV-exposed uninfected children$732,299
R01 · FY2024 · HD · contact PI
Metabolic impact of ART on women living with HIV and their infants$381,958
R01 · FY2024 · DK · contact PI
Appetite regulation with DTG based ART in postpartum women living with HIV and their infants (Ar-DART)$262,105
R21 · FY2024 · HD
Trial of Human Milk Oligosaccharide-based synbiotics for HIV-exposed uninfected children$713,526
R01 · FY2023 · HD · contact PI
Metabolic impact of ART on women living with HIV and their infants$391,424
R01 · FY2023 · DK · contact PI
Effect of Human Milk Oligosaccharide-based synbiotics on neurodevelopment of HIV-exposeduninfected children$352,048
R01 · FY2023 · HD · contact PI
Trial of Human Milk Oligosaccharide-based synbiotics for HIV-exposed uninfected children$643,360
R01 · FY2022 · HD · contact PI
Metabolic impact of ART on women living with HIV and their infants$399,850
R01 · FY2022 · DK · contact PI
Trial of Human Milk Oligosaccharide-based synbiotics for HIV-exposed uninfected children$700,756
R01 · FY2021 · HD · contact PI
MATERNAL INFLAMMATION, DIET AND GUT MICROBIOME IN HIV: IMPACT ON INFANT OUTCOMES$239,459
R00 · FY2020 · HD · contact PI
MATERNAL INFLAMMATION, DIET AND GUT MICROBIOME IN HIV: IMPACT ON INFANT OUTCOMES$243,230
R00 · FY2019 · HD · contact PI
MATERNAL INFLAMMATION, DIET AND GUT MICROBIOME IN HIV: IMPACT ON INFANT OUTCOMES$248,541
R00 · FY2018 · HD · contact PI
Maternal inflammation, diet and gut microbiome in HIV: impact on infant outcomes$131,198
K99 · FY2017 · HD · contact PI
Maternal inflammation, diet and gut microbiome in HIV: impact on infant outcomes$131,198
K99 · FY2016 · HD · contact PI